Detail
| LncRNA Name | SNHG16 |
| Synonyms | SNHG16, Nbla10727, Nbla12061, ncRAN |
| Region | GRCh38_17:76557766-76565348 Sequence |
| Ensembl | ENSG00000163597 |
| RefSeq | NR_038108 |
| Circulating | ✔ |
| Drug-resisitant | ✘ |
| Prognostic | ✔ |
| MiRNA | ✘ |
| Variant | ✘ |
| TF | ✘ |
| Methylation | ✘ |
| Cancer Name | bladder cancer |
| ICD-0-3 | C67 |
| Methods | qPCR etc. |
| Sample | serum, urine, bladder cancer tissues |
| Expression Pattern | up-regulated |
| Function Description | MEG3 was significantly down-regulated, SNHG16 and MALAT1 were significantly up-regulated in healthy vs. BCs and benign disease vs. BCs comparisons. |
| Pubmed ID | 27793008 |
| Year | 2016 |
| Title | Identification of a serum circulating lncRNA panel for the diagnosis and recurrence prediction of bladder cancer. |
| External Links |
| Links for SNHG16 | GenBank HGNC lncrnadb Noncode |
| Links for bladder cancer | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.